Skip to content
Unrated Drug recall · FDA · Published May 14, 2026

Fresenius Kabi Epinephrine Injection Recall: Failed Impurities May Cause Harm

Fresenius Kabi recalls specific batches of Epinephrine Injection due to failed impurities and degradations. Affected units may pose health risks if used improperly. Contact for details.

🇺🇸 FDA recall #D-0581-2026DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

Fresenius Kabi is recalling certain batches of Epinephrine Injection vials because they may contain impurities or degradations that could cause harm. This is a serious issue for people who need this medication in emergencies. Read more at govinfonow.com/recall/31308-fresenius-kabi-epinephrine-injection-recall-failed-impurities-may-cause-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/31308-fresenius-kabi-epinephrine-injection-recall-failed-impurities-may-cause-harm · Updated August 17, 2026 · FDA enforcement record: FDA #D-0581-2026

Cite this page

“Fresenius Kabi Epinephrine Injection Recall: Failed Impurities May Cause Harm.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31308-fresenius-kabi-epinephrine-injection-recall-failed-impurities-may-cause-harm. Based on FDA recall #D-0581-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0581-2026%22&limit=1).

The FDA announced on May 14, 2026, that Fresenius Kabi USA, LLC is recalling Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vials due to failed impurities and degradations specifications. The voluntary Class III recall affects 898,050 units distributed nationwide.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial
  • NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)
  • Batch # 6133313, Exp Date: 06/2026
  • Batch # 6133314, Exp Date: 06/2026
  • Batch # 6133315, Exp Date: 07/2026
  • Batch # 6133682, Exp Date: 09/2026
  • Batch # 6134812, Exp Date: 04/2027
  • Batch # 6134813, Exp Date: 04/2027

The hazard

The recall is due to failed impurities and degradations specifications. The FDA reported no specific incidents or injuries associated with this recall in the provided record.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since 2012-09-27. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (2026-08-10), Fresen: Morphine Syringes May Have Wrong Labeling (2026-08-04), and Fresenius Kabi Lidocaine HCl Injection Recall (2026-07-16). Other recent recalls of similar products include Fresenius Kabi Ketamine HCl Injection Recall (2026-02-05), American Regent Epinephrine Injection Recall (2026-08-11), and EPINEPHR: Sterility Risk in 1 mg/10mL Injection Recall (2026-04-01).

How to tell if you have this one

Check the NDC numbers: 63323-696-02 (vial) or 63323-696-25 (carton). Look for batch numbers 6133313, 6133314, 6133315, 6133682, 6134812, or 6134813 with expiration dates up to 09/2026.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC numbers and batch numbers listed in the recall notice to confirm if your vial is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: May 14, 202612. FDA classified it Class III: Jun 5, 202623. Published in FDA’s Enforcement Report: Jun 17, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0581-2026 (May 14, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0581-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA